# Sonos Inc: financial statements, quarterly

SONO · Nasdaq · CIK 1314727 · [Technology](/sectors/technology.md) · fiscal year ends Oct 3

Pages: [Overview](/companies/sono.md) · [Financials](/companies/sono/financials.md) · [Filings](/companies/sono/filings.md) · [Insiders](/companies/sono/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sono/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [305](/filings/0000950170-23-065135.md) | [613](/filings/0001314727-25-000026.md) | [253](/filings/0001314727-25-000056.md) | [397](/filings/0001314727-25-000074.md) | [255 d](/filings/0001314727-25-000090.md) | [551](/filings/0001314727-26-000032.md) | [260](/filings/0001314727-26-000061.md) | [345](/filings/0001314727-26-000086.md) | [288 d](/filings/0001314727-25-000090.md) | [546](/filings/0001314727-26-000032.md) | [282](/filings/0001314727-26-000061.md) | [375](/filings/0001314727-26-000086.md) |
| Cost of revenue | $m | [177 d](/filings/0001314727-25-000090.md) | [330](/filings/0001314727-25-000026.md) | [141](/filings/0001314727-25-000056.md) | [206](/filings/0001314727-25-000074.md) | [152 d](/filings/0001314727-25-000090.md) | [309](/filings/0001314727-26-000032.md) | [146](/filings/0001314727-26-000061.md) | [195](/filings/0001314727-26-000086.md) | [162 d](/filings/0001314727-25-000090.md) | [292](/filings/0001314727-26-000032.md) | [157](/filings/0001314727-26-000061.md) | [186](/filings/0001314727-26-000086.md) |
| Gross profit | $m | [128](/filings/0000950170-23-065135.md) | [283](/filings/0001314727-25-000026.md) | [112](/filings/0001314727-25-000056.md) | [192](/filings/0001314727-25-000074.md) | [103 d](/filings/0001314727-25-000090.md) | [241](/filings/0001314727-26-000032.md) | [114](/filings/0001314727-26-000061.md) | [150](/filings/0001314727-26-000086.md) | [126 d](/filings/0001314727-25-000090.md) | [253](/filings/0001314727-26-000032.md) | [125](/filings/0001314727-26-000061.md) | [189](/filings/0001314727-26-000086.md) |
| Research and development | $m | [65.5 d](/filings/0001314727-25-000090.md) | [79.2](/filings/0001314727-25-000026.md) | [80.3](/filings/0001314727-25-000056.md) | [74.2](/filings/0001314727-25-000074.md) | [70.8 d](/filings/0001314727-25-000090.md) | [80.8](/filings/0001314727-26-000032.md) | [77.4](/filings/0001314727-26-000061.md) | [59.8](/filings/0001314727-26-000086.md) | [62.0 d](/filings/0001314727-25-000090.md) | [59.8](/filings/0001314727-26-000032.md) | [64.1](/filings/0001314727-26-000061.md) | [67.9](/filings/0001314727-26-000086.md) |
| Operating income | $m | [(28.4) d](/filings/0001314727-25-000090.md) | [79.7](/filings/0001314727-25-000026.md) | [(71.0)](/filings/0001314727-25-000056.md) | [12.6](/filings/0001314727-25-000074.md) | [(69.4) d](/filings/0001314727-25-000090.md) | [48.1](/filings/0001314727-26-000032.md) | [(61.2)](/filings/0001314727-26-000061.md) | [(2.9)](/filings/0001314727-26-000086.md) | [(34.4) d](/filings/0001314727-25-000090.md) | [100](/filings/0001314727-26-000032.md) | [(31.6)](/filings/0001314727-26-000061.md) | [31.5](/filings/0001314727-26-000086.md) |
| Interest expense | $m | [0.1 d](/filings/0000950170-23-065135.md) | [0.1](/filings/0000950170-24-011840.md) | [0.1](/filings/0001314727-24-000009.md) | [0.1](/filings/0001314727-25-000074.md) | [0.1 d](/filings/0001314727-25-000090.md) | [0.1](/filings/0001314727-26-000032.md) | [0.1](/filings/0001314727-26-000061.md) | [0.1](/filings/0001314727-26-000086.md) | [0.1 d](/filings/0001314727-25-000090.md) | [0.1](/filings/0001314727-26-000032.md) | [0.1](/filings/0001314727-26-000061.md) | [0.1](/filings/0001314727-26-000086.md) |
| Income tax | $m | [(1.3) d](/filings/0001314727-25-000090.md) | [12.0](/filings/0001314727-25-000026.md) | [(0.7)](/filings/0001314727-25-000056.md) | [8.9](/filings/0001314727-25-000074.md) | [(9.2) d](/filings/0001314727-25-000090.md) | [(6.4)](/filings/0001314727-26-000032.md) | [11.0](/filings/0001314727-26-000061.md) | [2.6](/filings/0001314727-26-000086.md) | [3.5 d](/filings/0001314727-25-000090.md) | [8.3](/filings/0001314727-26-000032.md) | [(2.2)](/filings/0001314727-26-000061.md) | [4.4](/filings/0001314727-26-000086.md) |
| Net income | $m | [(31.2)](/filings/0000950170-23-065135.md) | [80.9](/filings/0001314727-25-000026.md) | [(69.7)](/filings/0001314727-25-000056.md) | [3.7](/filings/0001314727-25-000074.md) | [(53.1) d](/filings/0001314727-25-000090.md) | [50.2](/filings/0001314727-26-000032.md) | [(70.1)](/filings/0001314727-26-000061.md) | [(3.4)](/filings/0001314727-26-000086.md) | [(37.9) d](/filings/0001314727-25-000090.md) | [93.8](/filings/0001314727-26-000032.md) | [(28.9)](/filings/0001314727-26-000061.md) | [29.9](/filings/0001314727-26-000086.md) |
| Diluted EPS | $ per share | [(0.25)](/filings/0000950170-23-065135.md) | [0.64](/filings/0001314727-25-000026.md) | [(0.56)](/filings/0001314727-25-000056.md) | [0.03](/filings/0001314727-25-000074.md) | not reported | [0.40](/filings/0001314727-26-000032.md) | [(0.58)](/filings/0001314727-26-000061.md) | [(0.03)](/filings/0001314727-26-000086.md) | not reported | [0.75](/filings/0001314727-26-000032.md) | [(0.24)](/filings/0001314727-26-000061.md) | [0.25](/filings/0001314727-26-000086.md) |
| Basic EPS | $ per share | [(0.25)](/filings/0000950170-23-065135.md) | [0.65](/filings/0001314727-25-000026.md) | [(0.56)](/filings/0001314727-25-000056.md) | [0.03](/filings/0001314727-25-000074.md) | not reported | [0.41](/filings/0001314727-26-000032.md) | [(0.58)](/filings/0001314727-26-000061.md) | [(0.03)](/filings/0001314727-26-000086.md) | not reported | [0.78](/filings/0001314727-26-000032.md) | [(0.24)](/filings/0001314727-26-000061.md) | [0.25](/filings/0001314727-26-000086.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [220](/filings/0001314727-24-000026.md) | [170](/filings/0001314727-25-000026.md) | [246](/filings/0001314727-24-000009.md) | [227](/filings/0001314727-24-000017.md) | [170](/filings/0001314727-25-000090.md) | [280](/filings/0001314727-25-000026.md) | [173](/filings/0001314727-25-000056.md) | [201](/filings/0001314727-25-000074.md) | [175](/filings/0001314727-26-000086.md) | [313](/filings/0001314727-26-000032.md) | [200](/filings/0001314727-26-000061.md) | [207](/filings/0001314727-26-000086.md) |
| Current assets | $m | [660](/filings/0001314727-24-000026.md) | [759](/filings/0000950170-24-011840.md) | [583](/filings/0001314727-24-000009.md) | [604](/filings/0001314727-24-000017.md) | [551](/filings/0001314727-25-000090.md) | [613](/filings/0001314727-25-000026.md) | [453](/filings/0001314727-25-000056.md) | [503](/filings/0001314727-25-000074.md) | [504](/filings/0001314727-26-000086.md) | [640](/filings/0001314727-26-000032.md) | [540](/filings/0001314727-26-000061.md) | [592](/filings/0001314727-26-000086.md) |
| Total assets | $m | [1,002](/filings/0001314727-24-000026.md) | [1,110](/filings/0000950170-24-011840.md) | [926](/filings/0001314727-24-000009.md) | [961](/filings/0001314727-24-000017.md) | [916](/filings/0001314727-25-000090.md) | [964](/filings/0001314727-25-000026.md) | [792](/filings/0001314727-25-000056.md) | [834](/filings/0001314727-25-000074.md) | [823](/filings/0001314727-26-000086.md) | [948](/filings/0001314727-26-000032.md) | [839](/filings/0001314727-26-000061.md) | [882](/filings/0001314727-26-000086.md) |
| Current liabilities | $m | [354](/filings/0001314727-24-000026.md) | [376](/filings/0000950170-24-011840.md) | [303](/filings/0001314727-24-000009.md) | [367](/filings/0001314727-24-000017.md) | [366](/filings/0001314727-25-000090.md) | [373](/filings/0001314727-25-000026.md) | [290](/filings/0001314727-25-000056.md) | [316](/filings/0001314727-25-000074.md) | [352](/filings/0001314727-26-000086.md) | [388](/filings/0001314727-26-000032.md) | [341](/filings/0001314727-26-000061.md) | [367](/filings/0001314727-26-000086.md) |
| Total liabilities | $m | [484](/filings/0001314727-24-000026.md) | [516](/filings/0000950170-24-011840.md) | [432](/filings/0001314727-24-000009.md) | [497](/filings/0001314727-24-000017.md) | [488](/filings/0001314727-25-000090.md) | [494](/filings/0001314727-25-000026.md) | [409](/filings/0001314727-25-000056.md) | [435](/filings/0001314727-25-000074.md) | [468](/filings/0001314727-26-000086.md) | [505](/filings/0001314727-26-000032.md) | [455](/filings/0001314727-26-000061.md) | [479](/filings/0001314727-26-000086.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [519](/filings/0001314727-25-000090.md) | [594](/filings/0001314727-25-000056.md) | [494](/filings/0001314727-25-000074.md) | [464](/filings/0001314727-25-000074.md) | [429](/filings/0001314727-26-000086.md) | [469](/filings/0001314727-26-000061.md) | [383](/filings/0001314727-26-000086.md) | [399](/filings/0001314727-26-000086.md) | [355](/filings/0001314727-26-000086.md) | [443](/filings/0001314727-26-000061.md) | [384](/filings/0001314727-26-000086.md) | [404](/filings/0001314727-26-000086.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [22.2 d](/filings/0001314727-25-000090.md) | [275](/filings/0001314727-25-000026.md) | [(111) d](/filings/0001314727-25-000056.md) | [63.5 d](/filings/0001314727-25-000074.md) | [(37.7) d](/filings/0001314727-25-000090.md) | [156](/filings/0001314727-26-000032.md) | [(59.7) d](/filings/0001314727-26-000061.md) | [37.4 d](/filings/0001314727-26-000086.md) | [2.9 d](/filings/0001314727-25-000090.md) | [163](/filings/0001314727-26-000032.md) | [(65.4) d](/filings/0001314727-26-000061.md) | [46.2 d](/filings/0001314727-26-000086.md) |
| Capital expenditure | $m | [10.2 d](/filings/0000950170-23-065135.md) | [6.1](/filings/0001314727-25-000026.md) | [10.2 d](/filings/0001314727-25-000056.md) | [23.2 d](/filings/0001314727-25-000074.md) | [15.8 d](/filings/0001314727-25-000090.md) | [13.1](/filings/0001314727-26-000032.md) | [5.6 d](/filings/0001314727-26-000061.md) | [4.8 d](/filings/0001314727-26-000086.md) | [5.3 d](/filings/0001314727-25-000090.md) | [6.0](/filings/0001314727-26-000032.md) | [4.8 d](/filings/0001314727-26-000061.md) | [5.9 d](/filings/0001314727-26-000086.md) |
| Share repurchases | $m | [55.0 d](/filings/0001314727-25-000090.md) | [23.5](/filings/0001314727-25-000026.md) | [52.8 d](/filings/0001314727-25-000056.md) | [52.5 d](/filings/0001314727-25-000074.md) | [0.3 d](/filings/0001314727-25-000090.md) | [27.2](/filings/0001314727-26-000032.md) | [33.4 d](/filings/0001314727-26-000061.md) | [0.0 d](/filings/0001314727-26-000086.md) | [20.4 d](/filings/0001314727-25-000090.md) | [25.0](/filings/0001314727-26-000032.md) | [40.1 d](/filings/0001314727-26-000061.md) | [30.2 d](/filings/0001314727-26-000086.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-04-01) | Q3 FY2023 (2023-07-01) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [132](/filings/0000950170-24-011840.md) | [128](/filings/0001314727-24-000009.md) | [128](/filings/0001314727-24-000017.md) | [127](/filings/0001314727-25-000026.md) | [124](/filings/0001314727-25-000056.md) | [127](/filings/0001314727-25-000074.md) | [125](/filings/0001314727-26-000032.md) | [120](/filings/0001314727-26-000061.md) | [120](/filings/0001314727-26-000086.md) | [125](/filings/0001314727-26-000032.md) | [120](/filings/0001314727-26-000061.md) | [121](/filings/0001314727-26-000086.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 118,293,979 at 2026-07-20, from the cover of the [10-Q filed 2026-07-29](/filings/0001314727-26-000086.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.